Crossmark

Combined targeting of G protein‐coupled receptor and <scp>EGF</scp> receptor signaling overcomes resistance to <scp>PI</scp> 3K pathway inhibitors in <scp>PTEN</scp> ‐null triple negative breast cancer

Crossref DOI link: https://doi.org/10.15252/emmm.202011987

Published Online: 2020-07-16

Published Print: 2020-08-07

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Zecchin, Davide

Moore, Christopher

Michailidis, Fanourios

Horswell, Stuart

Rana, Sareena

Howell, Michael

Downward, Julian https://orcid.org/0000-0002-2331-4729
Funding

Funding for this research was provided by:

Cancer Research UK (FC001070)

Medical Research Council (FC001070)

Wellcome Trust (FC001070, 103799/Z/14/Z)

FP7 Ideas: European Research Council
License Information

Version of Record valid from 2020-07-16
More Information

Publication History

Received: 2020-01-06

Accepted: 2020-06-16

Published: 2020-07-16

Document is current

Any future updates will be listed below